Of these, 9 variants were found to overlap with our set of 24 variations, which were predicted as pathogenic, occurring in key cancer-associated genes such as SMAD4, IDH1, KRAS (at two distinct loci), TP53 (at three distinct loci), PTCH1, and MAP2K1. Here, KRAS is linked to cancer.